Research reveals how drug firms are charging health service such tall prices,some treatments can no longer be offered
Cancer patients are being denied drugs on the NHS that could lengthen their lives because of unnecessarily exorbitant prices, say experts.
The drugs are cheap to execute, and are available to patients in some other countries at much lower prices,according to new research.
Continue reading...
Source: theguardian.com